GlaxoSmithKline S.A.E (EGX: BIOC)

GlaxoSmithKline S.A.E Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	212.21	829.34	585.85	73.57	22.16	251.21
Cash & Short-Term Investments	212.21	829.34	585.85	73.57	22.16	251.21
Cash Growth	-32.08%	41.56%	696.36%	232.01%	-91.18%	-18.04%
Accounts Receivable	551.26	685.96	424.68	253.94	269.39	234.41
Other Receivables	59.82	23.89	318.64	408.81	221.5	492.69
Receivables	1,515	1,176	1,165	830.42	641.44	817.25
Inventory	1,105	695.27	485.89	500.45	456.05	342.62
Prepaid Expenses	-	-	-	17.58	20.46	43.96
Other Current Assets	153.43	164.7	216.65	126.47	143.34	99.96
Total Current Assets	2,986	2,866	2,454	1,548	1,283	1,555
Property, Plant & Equipment	604.11	572.14	548.11	540.21	476.53	451.27
Long-Term Investments	-	6.34	24.45	12.3	21.51	41
Goodwill	-	-	137.65	238.65	238.65	238.65
Long-Term Deferred Tax Assets	10.85	17.43	-	-	-	47.42
Other Long-Term Assets	111.13	96.48	21.33	85.09	97.2	52.81
Total Assets	3,712	3,558	3,185	2,425	2,117	2,386
Accounts Payable	167.74	424.53	176.8	104.54	49.28	68.39
Accrued Expenses	623.38	524.12	304.51	581.22	522.35	461.89
Short-Term Debt	518.64	-	-	118.21	145.73	235.16
Current Portion of Leases	33.54	28.39	17.48	29.52	-	-
Current Income Taxes Payable	116.08	97.93	308.57	17.38	1.23	41.89
Other Current Liabilities	242.87	448.98	585.89	161.22	170.56	169.37
Total Current Liabilities	1,702	1,524	1,393	1,012	889.15	976.71
Long-Term Leases	82.48	68.63	52.07	32.24	-	-
Long-Term Deferred Tax Liabilities	-	-	11.31	22.46	15.09	-
Total Liabilities	1,785	1,593	1,457	1,067	904.25	1,169
Common Stock	835.14	835.14	835.14	835.14	835.14	835.14
Retained Earnings	1,092	1,130	892.71	522.24	377.36	381.17
Total Common Equity	1,927	1,965	1,728	1,357	1,213	1,216
Minority Interest	0.59	0.6	0.58	0.58	0.59	0.57
Shareholders' Equity	1,927	1,965	1,728	1,358	1,213	1,217
Total Liabilities & Equity	3,712	3,558	3,185	2,425	2,117	2,386
Total Debt	634.65	97.03	69.55	179.97	145.73	235.16
Net Cash (Debt)	-422.44	732.32	516.3	-106.41	-123.58	16.05
Net Cash Growth	-	41.84%	-	-	-	-94.77%
Net Cash Per Share	-5.06	8.77	6.18	-1.27	-1.48	0.19
Filing Date Shares Outstanding	83.51	83.51	83.51	83.51	83.51	83.51
Total Common Shares Outstanding	83.51	83.51	83.51	83.51	83.51	83.51
Working Capital	1,284	1,342	1,060	536.41	394.3	578.29
Book Value Per Share	23.07	23.53	20.69	16.25	14.52	14.56
Tangible Book Value	1,927	1,965	1,590	1,119	973.85	977.66
Tangible Book Value Per Share	23.07	23.53	19.04	13.40	11.66	11.71
Land	17.59	17.59	12.65	12.65	12.65	12.65
Buildings	83.16	83.47	97.81	97.81	97.81	97.81
Machinery	711.28	668.83	662.18	629.59	571.91	352.87
Construction In Progress	132.53	108.51	88.86	98.67	122.98	298.17
Leasehold Improvements	26.81	26.81	26.85	42.34	42.34	32.88

Source: S&P Capital IQ. Standard template. Financial Sources.